Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: guarantee (67), certify (28), warrant (16)

InP methotrexate

Description: Chemotherapy Protocol LYMPHOMA METHOTREXATE Inpatient Regimen Regimen • Lymphoma – InP-Methotrexate Indication • Non-Hodgkin’s Lymphoma (NHL), i
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-methotrexate.pdf

InP-PAM-(cycles 5-6) v1

Description: Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Plea
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

Z-DEX dexamethasone idarubicin ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA Z-DEX-DEXAMETHASONE-IDARUBICIN Regimen Multiple Myeloma – Z-DEX-Dexamethasone-Ida
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Z-DEX-dexamethasone-idarubicin-ver1.pdf

CH003 SOP regimen validation full

Description: Standard Operating Procedure Validation of Chemotherapy Protocols in ARIA (Wessex) (SOP:CH003) 1. Objective 1.1 The purpose of this stand
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003-SOP-regimen-validation-full.pdf

Guidance for new grant holders_FINAL_June2021

Description: Guidance for new UHS* grant holders Congratulations, you’ve been awarded some research funding! Now what? What are th
Url: /Media/Southampton-Clinical-Research/Grants/Download/Guidance-for-new-grant-holders-FINAL-June2021.pdf

UHS support timeline for fellowships_2021

Description: UHS personal fellowship submissions Guidance on where to start, timelines and finding support Up to 1 year • Pre-submission preparations
Url: /Media/Southampton-Clinical-Research/Grants/Download/UHS-support-timeline-for-fellowships-2021.pdf

ObinutuzumabVenetoclax LowRisk

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Obinutuzumab-Venetoclax (Low Risk) Regimen • CLL – Obinutuzumab-Venetoclax (Low Risk) Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/ObinutuzumabVenetoclax-LowRisk.pdf

Institutional information_2021_final

Description: Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to a
Url: /Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2021-final.pdf

Parents participating in clinical ethics committees

Description: What is the role of a clinical ethics committee, and how much should patients' families be involved?
Url: /HealthProfessionals/Clinical-law-updates/Parents-participating-in-clinical-ethics-committees.aspx

Press release: Bowel cancer and emergency surgery survival in Southampton among best in country

Description: The rate of survival for patients undergoing bowel cancer surgery in Southampton is four times better than the national average.
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/December/Press-release-Bowel-cancer-and-emergency-surgery-survival-in-Southampton-among-best-in-country.aspx

241 to 250 of 1000

Previous … 23 24 25 26 27 … Next